Guardant Health, Inc. (GH)
USD 44.8
(-0.85%)
USD 44.8
(-0.85%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4.28 USD | 33.23% |
| 2022 | -6.41 USD | -68.68% |
| 2021 | -3.80 USD | -50.2% |
| 2020 | -2.53 USD | -237.33% |
| 2019 | -0.75 USD | 73.21% |
| 2018 | -2.80 USD | -137.29% |
| 2017 | -1.18 USD | -81.54% |
| 2016 | -0.65 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.84 USD | 10.64% |
| 2024 Q1 | -0.94 USD | 40.51% |
| 2023 Q3 | -0.73 USD | -8.96% |
| 2023 FY | - USD | 33.23% |
| 2023 Q2 | -0.67 USD | 48.46% |
| 2023 Q1 | -1.30 USD | 4.41% |
| 2023 Q4 | -1.58 USD | -116.44% |
| 2022 Q1 | -1.21 USD | -35.96% |
| 2022 FY | - USD | -68.68% |
| 2022 Q4 | -1.36 USD | 13.92% |
| 2022 Q3 | -1.58 USD | 29.78% |
| 2022 Q2 | -2.25 USD | -85.95% |
| 2021 FY | - USD | -50.2% |
| 2021 Q4 | -0.89 USD | 16.04% |
| 2021 Q3 | -1.06 USD | -10.42% |
| 2021 Q2 | -0.96 USD | 11.93% |
| 2021 Q1 | -1.09 USD | -15.96% |
| 2020 Q4 | -0.94 USD | -20.51% |
| 2020 Q3 | -0.78 USD | -36.84% |
| 2020 Q2 | -0.57 USD | -96.55% |
| 2020 Q1 | -0.29 USD | -7.41% |
| 2020 FY | - USD | -237.33% |
| 2019 Q1 | -0.30 USD | 0.0% |
| 2019 Q4 | -0.27 USD | -92.86% |
| 2019 Q3 | -0.14 USD | -7.69% |
| 2019 FY | - USD | 73.21% |
| 2019 Q2 | -0.13 USD | 56.67% |
| 2018 Q4 | -0.30 USD | -3.45% |
| 2018 Q2 | -0.26 USD | -30.0% |
| 2018 Q1 | -0.20 USD | 4.76% |
| 2018 FY | - USD | -137.29% |
| 2018 Q3 | -0.29 USD | -11.54% |
| 2017 Q1 | -1.54 USD | 0.0% |
| 2017 FY | - USD | -81.54% |
| 2017 Q3 | -0.40 USD | 77.53% |
| 2017 Q2 | -1.78 USD | -15.58% |
| 2017 Q4 | -0.21 USD | 47.5% |
| 2016 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | -237.008% |
| Applied DNA Sciences, Inc. | -15.21 USD | 71.861% |
| Aspira Women's Health Inc. | -1.81 USD | -136.464% |
| Biodesix, Inc. | -0.64 USD | -568.75% |
| BioNexus Gene Lab Corp. | -0.17 USD | -2417.647% |
| bioAffinity Technologies, Inc. | -0.91 USD | -370.33% |
| bioAffinity Technologies, Inc. | -0.91 USD | -370.33% |
| Bionano Genomics, Inc. | -6.81 USD | 37.151% |
| CareDx, Inc | -3.54 USD | -20.904% |
| Check-Cap Ltd. | -3.00 USD | -42.667% |
| Castle Biosciences, Inc. | -2.14 USD | -100.0% |
| DarioHealth Corp. | -1.93 USD | -121.762% |
| Exact Sciences Corporation | -1.13 USD | -278.761% |
| Fulgent Genetics, Inc. | -5.63 USD | 23.979% |
| ICON Public Limited Company | 7.46 USD | 157.373% |
| IDEXX Laboratories, Inc. | 10.17 USD | 142.085% |
| Illumina, Inc. | -7.35 USD | 41.769% |
| Intelligent Bio Solutions Inc. | -6.38 USD | 32.915% |
| iSpecimen Inc. | -1.23 USD | -247.967% |
| Standard BioTools Inc. | -0.94 USD | -355.319% |
| MDxHealth SA | -1.66 USD | -157.831% |
| 23andMe Holding Co. | -1.40 USD | -205.714% |
| Medpace Holdings, Inc. | 9.20 USD | 146.522% |
| Myriad Genetics, Inc. | -1.39 USD | -207.914% |
| Mainz Biomed B.V. | -1.62 USD | -164.198% |
| ENDRA Life Sciences Inc. | -1.11 USD | -285.586% |
| NeoGenomics, Inc. | -0.70 USD | -511.429% |
| Neogen Corporation | -0.04 USD | -9739.08% |
| Inotiv, Inc. | -4.10 USD | -4.39% |
| Natera, Inc. | -3.78 USD | -13.228% |
| OpGen, Inc. | -41.47 USD | 89.679% |
| OPKO Health, Inc. | -0.25 USD | -1612.0% |
| Psychemedics Corporation | -0.72 USD | -494.444% |
| Prenetics Global Limited | -5.58 USD | 23.297% |
| Prenetics Global Limited | -5.58 USD | 23.297% |
| Precipio, Inc. | -4.51 USD | 5.1% |
| Personalis, Inc. | -2.25 USD | -90.222% |
| RadNet, Inc. | 0.05 USD | 9035.282% |
| Sera Prognostics, Inc. | -1.16 USD | -268.966% |
| Sotera Health Company | 0.18 USD | 2477.778% |
| Neuronetics, Inc. | -1.05 USD | -307.619% |
| Star Equity Holdings, Inc. | 7.42 USD | 157.682% |
| Star Equity Holdings, Inc. | 7.42 USD | 157.682% |
| Trinity Biotech plc | -3.14 USD | -36.306% |
| T2 Biosystems, Inc. | -19.19 USD | 77.697% |
| Twist Bioscience Corporation | -3.60 USD | -18.889% |
| Exagen Inc. | -1.34 USD | -219.403% |